Cargando…

LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells

[Image: see text] Metabolism plays a fundamental role in regulating cellular functions and fate decisions. Liquid chromatography-mass spectrometry (LC-MS)-based targeted metabolomic approaches provide high-resolution insights into the metabolic state of a cell. However, the typical sample size is in...

Descripción completa

Detalles Bibliográficos
Autores principales: Schönberger, Katharina, Mitterer, Michael, Glaser, Katharina, Stecher, Manuel, Hobitz, Sebastian, Schain-Zota, Dominik, Schuldes, Konrad, Lämmermann, Tim, Rambold, Angelika S., Cabezas-Wallscheid, Nina, Buescher, Joerg M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996616/
https://www.ncbi.nlm.nih.gov/pubmed/36812587
http://dx.doi.org/10.1021/acs.analchem.2c04396
_version_ 1784903084524175360
author Schönberger, Katharina
Mitterer, Michael
Glaser, Katharina
Stecher, Manuel
Hobitz, Sebastian
Schain-Zota, Dominik
Schuldes, Konrad
Lämmermann, Tim
Rambold, Angelika S.
Cabezas-Wallscheid, Nina
Buescher, Joerg M.
author_facet Schönberger, Katharina
Mitterer, Michael
Glaser, Katharina
Stecher, Manuel
Hobitz, Sebastian
Schain-Zota, Dominik
Schuldes, Konrad
Lämmermann, Tim
Rambold, Angelika S.
Cabezas-Wallscheid, Nina
Buescher, Joerg M.
author_sort Schönberger, Katharina
collection PubMed
description [Image: see text] Metabolism plays a fundamental role in regulating cellular functions and fate decisions. Liquid chromatography-mass spectrometry (LC-MS)-based targeted metabolomic approaches provide high-resolution insights into the metabolic state of a cell. However, the typical sample size is in the order of 10(5)–10(7) cells and thus not compatible with rare cell populations, especially in the case of a prior flow cytometry-based purification step. Here, we present a comprehensively optimized protocol for targeted metabolomics on rare cell types, such as hematopoietic stem cells and mast cells. Only 5000 cells per sample are required to detect up to 80 metabolites above background. The use of regular-flow liquid chromatography allows for robust data acquisition, and the omission of drying or chemical derivatization avoids potential sources of error. Cell-type-specific differences are preserved while the addition of internal standards, generation of relevant background control samples, and targeted metabolite with quantifiers and qualifiers ensure high data quality. This protocol could help numerous studies to gain thorough insights into cellular metabolic profiles and simultaneously reduce the number of laboratory animals and the time-consuming and costly experiments associated with rare cell-type purification.
format Online
Article
Text
id pubmed-9996616
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-99966162023-03-10 LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells Schönberger, Katharina Mitterer, Michael Glaser, Katharina Stecher, Manuel Hobitz, Sebastian Schain-Zota, Dominik Schuldes, Konrad Lämmermann, Tim Rambold, Angelika S. Cabezas-Wallscheid, Nina Buescher, Joerg M. Anal Chem [Image: see text] Metabolism plays a fundamental role in regulating cellular functions and fate decisions. Liquid chromatography-mass spectrometry (LC-MS)-based targeted metabolomic approaches provide high-resolution insights into the metabolic state of a cell. However, the typical sample size is in the order of 10(5)–10(7) cells and thus not compatible with rare cell populations, especially in the case of a prior flow cytometry-based purification step. Here, we present a comprehensively optimized protocol for targeted metabolomics on rare cell types, such as hematopoietic stem cells and mast cells. Only 5000 cells per sample are required to detect up to 80 metabolites above background. The use of regular-flow liquid chromatography allows for robust data acquisition, and the omission of drying or chemical derivatization avoids potential sources of error. Cell-type-specific differences are preserved while the addition of internal standards, generation of relevant background control samples, and targeted metabolite with quantifiers and qualifiers ensure high data quality. This protocol could help numerous studies to gain thorough insights into cellular metabolic profiles and simultaneously reduce the number of laboratory animals and the time-consuming and costly experiments associated with rare cell-type purification. American Chemical Society 2023-02-22 /pmc/articles/PMC9996616/ /pubmed/36812587 http://dx.doi.org/10.1021/acs.analchem.2c04396 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Schönberger, Katharina
Mitterer, Michael
Glaser, Katharina
Stecher, Manuel
Hobitz, Sebastian
Schain-Zota, Dominik
Schuldes, Konrad
Lämmermann, Tim
Rambold, Angelika S.
Cabezas-Wallscheid, Nina
Buescher, Joerg M.
LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells
title LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells
title_full LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells
title_fullStr LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells
title_full_unstemmed LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells
title_short LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells
title_sort lc-ms-based targeted metabolomics for facs-purified rare cells
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996616/
https://www.ncbi.nlm.nih.gov/pubmed/36812587
http://dx.doi.org/10.1021/acs.analchem.2c04396
work_keys_str_mv AT schonbergerkatharina lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells
AT mitterermichael lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells
AT glaserkatharina lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells
AT stechermanuel lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells
AT hobitzsebastian lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells
AT schainzotadominik lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells
AT schuldeskonrad lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells
AT lammermanntim lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells
AT ramboldangelikas lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells
AT cabezaswallscheidnina lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells
AT buescherjoergm lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells